{"id":"F2013L01924","name":"Therapeutic Goods (Listing) Notice 2013 (No. 5)","slug":"therapeutic-goods-listing-notice-2013-no-5","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":128057,"registerId":"commonwealth-F2013L01924-current","compilationNumber":null,"startDate":"2026-04-03","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"Therapeutic Goods (Listing) Notice 2013 (No. 5)","content":"Therapeutic Goods Act 1989\n\nTherapeutic Goods (Listing) Notice 2013 (No. 5)\n\nI, JOHN SKERRITT, National Manager of the Therapeutic Goods Administration, delegate of the Minister for Health for the purposes of subsection 9A(5) of the Therapeutic Goods Act 1989 (the Act) and acting under that provision, require the following therapeutic goods to be included in the part of the Australian Register of Therapeutic Goods (the Register) for listed goods:\n\n    preparations, for the purpose of Item 3 of Part 1 of Schedule 4 to the Therapeutic Goods Regulations 1990 (the Regulations), that contain ‘Calcium L-threonate’ as a therapeutically active ingredient, subject to the following conditions:\n\n        the preparations are for oral use only.\n\nThis Notice commences from the day after it is registered on the Federal Register of Legislative Instruments.\n\nPursuant to subsection 9A(6) of the Act, this Notice ceases to have effect on the day that amendments to the Regulations come into effect to require inclusion of the therapeutic goods listed in this Notice in the part of the Register for listed goods.\n\nDated this 1st day of November 2013\n\n(Signed by)\n\nJohn Skerritt\n\nDelegate of the Minister for Health","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":1589},"content_quality":"ok","complexity_score":1,"scope_assessment":{"changed":false,"description":"The notice maintains its original purpose of temporarily listing a specific therapeutic ingredient pending permanent regulatory amendment."},"complexity_factors":["Single active ingredient specified","Single operational condition (oral use only)","Minimal cross-referencing to parent Act and Regulations","Temporary mechanism with automatic cessation trigger"],"plain_english_summary":"This notice temporarily allows **calcium L-threonate** supplements to be sold in Australia as \"listed medicines\" (a lower-risk category of therapeutic goods that includes many vitamins and supplements).\n\n**What it does:**\n- Adds calcium L-threonate preparations to the Australian Register of Therapeutic Goods (ARTG) — the official database of medicines allowed to be sold here.\n- This approval acts as a \"placeholder\" until permanent regulations are officially updated to include this ingredient.\n\n**Key restriction:**\n- These products must be for **oral use only** (such as tablets, capsules, or powders you swallow). They cannot be injections, creams, or other non-oral forms.\n\n**Why it matters:**\nWithout this notice, products containing calcium L-threonate (a specific form of calcium supplement) could not be legally supplied in Australia. This provides temporary legal access while the formal regulations are amended."}},"importantCases":[],"_links":{"self":"/api/acts/therapeutic-goods-listing-notice-2013-no-5","history":"/api/acts/therapeutic-goods-listing-notice-2013-no-5/history","analysis":"/api/acts/therapeutic-goods-listing-notice-2013-no-5/analysis","conflicts":"/api/acts/therapeutic-goods-listing-notice-2013-no-5/conflicts","importantCases":"/api/acts/therapeutic-goods-listing-notice-2013-no-5/important-cases","documents":"/api/acts/therapeutic-goods-listing-notice-2013-no-5/documents"}}